InvestorsHub Logo
Followers 11
Posts 3235
Boards Moderated 0
Alias Born 01/06/2007

Re: johnnyfiber post# 64080

Sunday, 06/03/2007 12:55:23 PM

Sunday, June 03, 2007 12:55:23 PM

Post# of 82595
I believe DnaPrints' technology is key for many companies. DnaPrints' Patents cover a wide spectrum in the Pharma Industry. It was stated as such by Gabriel. I believe Merck is playing catch-up with the M2Gen deal. This will most certainly give DnaPrint needed leverage in any restructuring, buy-out,etc... Of course a product to market will be the cherry on our Sh-t Sundae...